🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 11% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

30 Gram(s) Serving Size
30 Servings
Other Combinations Product Type
11% Evidence Coverage

Supplement Facts — Evidence Check

Calories
110 {Calories}
Total Fat
(1% DV)
Cholesterol
5 mg (2% DV)
Total Carbohydrates
3 g (1% DV)
Protein
25 g (50% DV)
Calcium
110 mg (11% DV)
70 mg (8% DV)
✅ Within RDA (0.1× RDA of 700 mg) 📚 12 studies (Tier A: 0, B: 3)
RDA 700mg This product: 70mg UL 4000mg
Sodium
110 mg (5% DV)
Potassium
300 mg (9% DV)

Other Ingredients

Whey Protein isolate COCOA POWDER Natural and Artificial flavor Whey Protein hydrolysate Medium Chain Triglycerides Potassium Citrate Sodium Citrate Cellulose Gum Xanthan Gum Carrageenan Acesulfame Potassium Sucralose Soy Lecithin

Label Claims — Verification

All Other
All Other (98% of products) Structure/Function (89% of products) Nutrient (76% of products)

Target Groups

Adult (18 - 50 Years) Sugar Free

Product Information

📋 Directions for Use

DIRECTIONS Mix one scoop (30g) in 8 ounces of cold water.

⚠️ Warnings & Precautions

ALLERGEN STATEMENT: THIS PRODUCT CONTAINS INGREDIENTS DERIVED FROM MILK, AND SOY. THIS PRODUCT WAS MANUFACTURED IN A FACILITY THAT PROCESSES MILK, SOY, WHEAT AND EGGS.

🧪 Formulation Notes

20 g PROTEIN

SUGAR & LACTOSE FREE

MANUFACTURED FREE OF BANNED SUBSTANCES IN A NSF GMP FOR SPORT FACILITY

Additional Information

PREMIUM WHEY PROTEIN

Grams of Amino Acids per 100 grams of pure protein ESSENTIAL AMINO ACIDS L-Leucine (BCAA) .........11.5g L-Isoleucine (BCAA)........6.5g L-Valine (BCAA).............6.2g L-Lysine.......................9.6g L-Threonine...................6.8g L-Methionine...................2.2g L-Phenylalanine................3.5g L-Tryptophan...................1.8g Exceptional BCAA to EAA Ratio TOTAL OF BCAA (24.2) ------------------------------- =50.3 TOTAL OF EAA (48.1) CONDITIONALLY ESSENTIAL AMINO ACIDS L-Arginine .........................2.5g L-Histidine........................2.0g NON-ESSENTIAL AMINO ACIDS L-Alanine....................5.2g L-Aspartic Acid.............11.2g L-Glutamic Acid............12.5g L-Glycine...................1.9g L-Proline...................5.9g L-Serine....................4.9g L-Tyrosine.................3.2g L-Cysteine................2.6g

RICH IN BCAAs

PRE DURING POST

Product Details

DSLD Entry Date 2012-10-01
Product Type Other Combinations
Form Powder
Brand CytoSport
DSLD ID 12943
Data Updated 2026-04-11

Research Evidence

46 Research Sources
55 Avg Quality Score
23 Meta Analysis
7 Systematic Review
7 Rct
4 Clinical Trial
2 Other
1 Guideline
1 Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024
View all evidence for Phosphorus →

Compare Similar Products

View all Phosphorus products →